How to manage children and young adults with myeloproliferative neoplasms
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
How to manage children and young adults with myeloproliferative neoplasms
Authors
Keywords
-
Journal
LEUKEMIA
Volume 26, Issue 7, Pages 1452-1457
Publisher
Springer Nature
Online
2012-01-18
DOI
10.1038/leu.2012.12
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interferon Alfa in the Treatment of Philadelphia-Negative Chronic Myeloproliferative Neoplasms
- (2011) Hans Carl Hasselbalch et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety and Efficacy of TG101348, a Selective JAK2 Inhibitor, in Myelofibrosis
- (2011) Animesh Pardanani et al. JOURNAL OF CLINICAL ONCOLOGY
- Philadelphia-Negative Classical Myeloproliferative Neoplasms: Critical Concepts and Management Recommendations From European LeukemiaNet
- (2011) Tiziano Barbui et al. JOURNAL OF CLINICAL ONCOLOGY
- Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study
- (2011) Tiziano Barbui et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment-Related Risk Factors for Transformation to Acute Myeloid Leukemia and Myelodysplastic Syndromes in Myeloproliferative Neoplasms
- (2011) Magnus Björkholm et al. JOURNAL OF CLINICAL ONCOLOGY
- Myeloproliferative Neoplasms: Molecular Pathophysiology, Essential Clinical Understanding, and Treatment Strategies
- (2011) Ayalew Tefferi et al. JOURNAL OF CLINICAL ONCOLOGY
- Hydroxyurea in essential thrombocythemia: rate and clinical relevance of responses by European LeukemiaNet criteria
- (2010) A. Carobbio et al. BLOOD
- Observation versus antiplatelet therapy as primary prophylaxis for thrombosis in low-risk essential thrombocythemia
- (2010) A. Alvarez-Larran et al. BLOOD
- Allogeneic hematopoietic cell transplantation versus drugs in myelofibrosis: the risk-benefit balancing act
- (2010) A Tefferi BONE MARROW TRANSPLANTATION
- Guideline for investigation and management of adults and children presenting with a thrombocytosis
- (2010) Claire N. Harrison et al. BRITISH JOURNAL OF HAEMATOLOGY
- Long-term follow-up of essential thrombocythemia in young adults: treatment strategies, major thrombotic complications and pregnancy outcomes. A study of 76 patients
- (2010) F. Palandri et al. HAEMATOLOGICA
- Treatment outcome in a cohort of young patients with polycythemia vera
- (2010) Marco Ruggeri et al. Internal and Emergency Medicine
- Safety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis
- (2010) Srdan Verstovsek et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical and hematological presentation of children and adolescents with polycythemia vera
- (2009) Holger Cario et al. ANNALS OF HEMATOLOGY
- Response criteria for essential thrombocythemia and polycythemia vera: result of a European LeukemiaNet consensus conference
- (2009) G. Barosi et al. BLOOD
- Thrombosis in primary myelofibrosis: incidence and risk factors
- (2009) T. Barbui et al. BLOOD
- The role of cytogenetic abnormalities as a prognostic marker in primary myelofibrosis: applicability at the time of diagnosis and later during disease course
- (2009) C. S. Tam et al. BLOOD
- The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
- (2009) J. W. Vardiman et al. BLOOD
- Karyotype complements the International Prognostic Scoring System for primary myelofibrosis
- (2009) Kebede Hussein et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Bone Marrow Fibrosis and Diagnosis of Essential Thrombocythemia
- (2009) Juergen Thiele et al. JOURNAL OF CLINICAL ONCOLOGY
- Reticulin Accumulation in Essential Thrombocythemia: Prognostic Significance and Relationship to Therapy
- (2009) Peter J. Campbell et al. JOURNAL OF CLINICAL ONCOLOGY
- Pegylated Interferon Alfa-2a Yields High Rates of Hematologic and Molecular Response in Patients With Advanced Essential Thrombocythemia and Polycythemia Vera
- (2009) Alfonso Quintás-Cardama et al. JOURNAL OF CLINICAL ONCOLOGY
- Secondary Myelofibrosis in Children
- (2009) Rahul Naithani et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- The JAK2 46/1 haplotype confers susceptibility to essential thrombocythemia regardless of JAK2V617F mutational status—clinical correlates in a study of 226 consecutive patients
- (2009) A Pardanani et al. LEUKEMIA
- Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera
- (2008) J.-J. Kiladjian et al. BLOOD
- Increased risks of polycythemia vera, essential thrombocythemia, and myelofibrosis among 24 577 first-degree relatives of 11 039 patients with myeloproliferative neoplasms in Sweden
- (2008) O. Landgren et al. BLOOD
- New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment
- (2008) F. Cervantes et al. BLOOD
- Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments
- (2008) V. De Stefano et al. HAEMATOLOGICA
- Frequency and clinical features of theJAK2V617F mutation in pediatric patients with sporadic essential thrombocythemia
- (2008) Takuya Nakatani et al. PEDIATRIC BLOOD & CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started